Arch Therapeutics, Inc.·4

Aug 19, 4:07 PM ET

Arch Therapeutics, Inc. 4

4 · Arch Therapeutics, Inc. · Filed Aug 19, 2015

Insider Transaction Report

Form 4
Period: 2015-08-18
DAVIS RICHARD E
CFO & TREASURER
Transactions
  • Award

    Stock Option (right to buy)

    2015-08-18+175,000175,000 total
    Exercise: $0.28Exp: 2025-08-17Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]Of the Shares subject to the Option, 25% shall vest immediately upon August 18, 2015, and 1/36 of the remaining unvested Shares subject to the Option shall vest on each of the next thirty-six (36) monthly anniversaries.

Documents

1 file
  • 4
    v418648_4.xmlPrimary

    OWNERSHIP DOCUMENT